Knoxville, Tennessee - February 27, 2026 - PRESSADVANTAGE - Cover Pro Roofing has announced the availability of metal ...

COMBRIAX is the world's first flu plus COVID combination vaccine to receive a positive CHMP opinion recommending ...

Creative Biolabs expands its research capabilities, offering diversified tools and services to support global biomedical innovation. SHIRLEY, NY, UNITED STATES, February 27, 2026 /EINPresswire.com/ — ...

Real-Time Event Support, Intelligent Call Routing, AI Registration Workflows & High-Margin SaaS Monetization Across ...

AI-driven search behavior, and how brands can stay visible as traditional search evolves. If AI systems can’t clearly interpret and represent your brand, you’re missing a growing share of visibility.

The year ended strongly with an important milestone; the license and option agreement with Moderna, which is an important validation of our technology and has created favourable conditions for 2026 an ...

A breakthrough personalized mRNA cancer vaccine that trains the immune system to target patients' unique tumor mutations is showing promising results. Five-year trial data show the risk of recurrence ...

Moderna Chief Medical Officer Jacqueline Miller, M.D., is stepping down after a little more than a year in the role. As of publication, Moderna has not responded to Fierce Biotech’s questions about a ...

Moderna Inc.’s chief executive officer said the company doesn’t plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from US officials. “You cannot make a ...

Moderna and Merck’s cancer vaccine reduced the risk of relapse or death for melanoma patients, five-year data from a Phase 2b trial showed. The companies on Tuesday said the vaccine, in combination ...

A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.